ScoutQuest8 Oct 2026
Aarti Drugs524348New rating assigned

Crisil ESG Ratings assigns 'Crisil ESG 61' (Strong) rating based on FY 2025-26 data

Crisil ESG Ratings has assigned Aarti Drugs an ESG rating of 'Crisil ESG 61' (Strong), based on data pertaining to FY 2025-26.

ESG Rating Assigned
'Crisil ESG 61' (Strong)
Rating Basis Period
FY 2025-26
Report Received Date
October 7, 2026

The disclosure in short

What an ESG rating is

ESG stands for Environmental, Social and Governance. An ESG rating is a third-party view of how a company performs on these non-financial aspects, such as how it manages its environmental impact, how it deals with employees and the wider community, and how it governs itself. Here, Crisil ESG Ratings has assigned a score of 61 to the company, with the descriptive tag 'Strong'.

Why the company's clarification matters

The company has specifically noted that it did not engage Crisil ESG Ratings for this exercise. That means the rating was not commissioned by the company; it was prepared independently by the rating provider from publicly available data. Investors reading this update can note both the score itself and the fact that it comes from an independent assessment rather than a company-requested one.

Points to keep in mind

In simple terms, the update tells investors how an external agency has scored the company on environment, social and governance parameters, and makes clear where that assessment came from.

More numbers
  • Crisil ESG rating assignedCrisil ESG 61
Source: BSE · 8 Oct 2026

Nothing here is a view, opinion or recommendation of ScoutQuest, its parent, directors or employees. ScoutQuest is a technology company: this page was assembled automatically from public sources using artificial intelligence, and may contain errors or omissions. Confirm everything against the original source before you act on it. Any use of this page is at your own risk, and neither ScoutQuest nor its parent, directors or employees accepts liability for it.